Skip to main contentSkip to navigation
Sirius Investors
Novan, Inc.

Novan, Inc.

NOVN
NASDAQHealthcare

Revenue Analysis - NOVN

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

NOVN Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Product

0.0% of total revenue

$2.4M

Rhofade

0.0% of total revenue

$1.1M

Minolira

0.0% of total revenue

$345.0K

Cloderm

0.0% of total revenue

$218.0K

Manufactured Product, Other

0.0% of total revenue

$217.0K

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Cloderm
Manufactured Product, Other
Minolira
Product
Rhofade
3/31/2023$218.0K$217.0K$345.0K$2.4M$1.1M
12/31/2022$118.0K$238.0K$808.0K$4.7M$2.9M
9/30/2022$148.0K$197.0K$374.0K$4.6M$3.5M
6/30/2022$197.0K$397.0K$312.0K$5.8M$4.3M
3/31/2022$42.0K$-240000$78.0K$718.0K$838.0K

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Cloderm+84.7%
Declining Segments
Rhofade-62.4%
Minolira-57.3%
Product-48.3%

Earnings Reports

Want to see how NOVN's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports